Maze Net Interest Income from 2010 to 2026
| MAZE Stock | 47.22 1.15 2.38% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 5.4 M | Current Value 3.2 M | Quarterly Volatility 1 M |
Check Maze Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maze Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 3.2 M, Interest Income of 3.2 M or Depreciation And Amortization of 3 M, as well as many indicators such as Price To Sales Ratio of 3.34, Dividend Yield of 0.0 or PTB Ratio of 3.88. Maze financial statements analysis is a perfect complement when working with Maze Therapeutics Valuation or Volatility modules.
Maze | Net Interest Income | Build AI portfolio with Maze Stock |
Analyzing Maze Therapeutics's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Maze Therapeutics's current valuation and future prospects.
Latest Maze Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Maze Therapeutics Common over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Maze Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Maze Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Maze Net Interest Income Regression Statistics
| Arithmetic Mean | 2,441,590 | |
| Geometric Mean | 2,310,501 | |
| Coefficient Of Variation | 41.40 | |
| Mean Deviation | 688,502 | |
| Median | 2,028,000 | |
| Standard Deviation | 1,010,807 | |
| Sample Variance | 1T | |
| Range | 3.4M | |
| R-Value | 0.59 | |
| Mean Square Error | 715.6B | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 117,299 | |
| Total Sum of Squares | 16.3T |
Maze Net Interest Income History
About Maze Therapeutics Financial Statements
Maze Therapeutics stakeholders use historical fundamental indicators, such as Maze Therapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Maze Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Maze Therapeutics' assets and liabilities are reflected in the revenues and expenses on Maze Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Maze Therapeutics Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 5.4 M | 3.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Maze Therapeutics Common is a strong investment it is important to analyze Maze Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Maze Therapeutics' future performance. For an informed investment choice regarding Maze Stock, refer to the following important reports:Check out the analysis of Maze Therapeutics Correlation against competitors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Pharmaceuticals sector continue expanding? Could Maze diversify its offerings? Factors like these will boost the valuation of Maze Therapeutics. Expected growth trajectory for Maze significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Maze Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Maze Therapeutics Common is measured differently than its book value, which is the value of Maze that is recorded on the company's balance sheet. Investors also form their own opinion of Maze Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Maze Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Maze Therapeutics' market value can be influenced by many factors that don't directly affect Maze Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Maze Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maze Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Maze Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.